UniProt ID | SH319_HUMAN | |
---|---|---|
UniProt AC | Q5HYK7 | |
Protein Name | SH3 domain-containing protein 19 | |
Gene Name | SH3D19 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 790 | |
Subcellular Localization | Cytoplasm . Nucleus . Is recruited to the nucleus by the KMT2A/MLL1-EEN fusion protein. | |
Protein Description | May play a role in regulating A disintegrin and metalloproteases (ADAMs) in the signaling of EGFR-ligand shedding. May be involved in suppression of Ras-induced cellular transformation and Ras-mediated activation of ELK1. Plays a role in the regulation of cell morphology and cytoskeletal organization.. | |
Protein Sequence | MNIMNTEQSQNSIVSRIKVFEGQTNIETSGLPKKPEITPRSLPPKPTVSSGKPSVAPKPAANRASGEWDSGTENRLKVTSKEGLTPYPPLQEAGSIPVTKPELPKKPNPGLIRSVNPEIPGRGPLAESSDSGKKVPTPAPRPLLLKKSVSSENPTYPSAPLKPVTVPPRLAGASQAKAYKSLGEGPPANPPVPVLQSKPLVDIDLISFDDDVLPTPSGNLAEESVGSEMVLDPFQLPAKTEPIKERAVQPAPTRKPTVIRIPAKPGKCLHEDPQSPPPLPAEKPIGNTFSTVSGKLSNVERTRNLESNHPGQTGGFVRVPPRLPPRPVNGKTIPTQQPPTKVPPERPPPPKLSATRRSNKKLPFNRSSSDMDLQKKQSNLATGLSKAKSQVFKNQDPVLPPRPKPGHPLYSKYMLSVPHGIANEDIVSQNPGELSCKRGDVLVMLKQTENNYLECQKGEDTGRVHLSQMKIITPLDEHLRSRPNDPSHAQKPVDSGAPHAVVLHDFPAEQVDDLNLTSGEIVYLLEKIDTDWYRGNCRNQIGIFPANYVKVIIDIPEGGNGKRECVSSHCVKGSRCVARFEYIGEQKDELSFSEGEIIILKEYVNEEWARGEVRGRTGIFPLNFVEPVEDYPTSGANVLSTKVPLKTKKEDSGSNSQVNSLPAEWCEALHSFTAETSDDLSFKRGDRIQILERLDSDWCRGRLQDREGIFPAVFVRPCPAEAKSMLAIVPKGRKAKALYDFRGENEDELSFKAGDIITELESVDDDWMSGELMGKSGIFPKNYIQFLQIS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Phosphorylation | --MNIMNTEQSQNSI --CCCCCHHHHHCHH | 20.30 | - | |
9 | Phosphorylation | NIMNTEQSQNSIVSR CCCCHHHHHCHHHHE | 25.71 | - | |
18 | Ubiquitination | NSIVSRIKVFEGQTN CHHHHEEEEEECCCC | 39.50 | - | |
34 | Ubiquitination | ETSGLPKKPEITPRS CCCCCCCCCCCCCCC | 46.04 | - | |
45 | Ubiquitination | TPRSLPPKPTVSSGK CCCCCCCCCCCCCCC | 51.92 | - | |
52 | Ubiquitination | KPTVSSGKPSVAPKP CCCCCCCCCCCCCCC | 35.75 | - | |
65 | Phosphorylation | KPAANRASGEWDSGT CCCCCCCCCCCCCCC | 33.73 | 25159151 | |
70 | Phosphorylation | RASGEWDSGTENRLK CCCCCCCCCCCCEEE | 49.00 | 28102081 | |
72 | Phosphorylation | SGEWDSGTENRLKVT CCCCCCCCCCEEEEE | 33.76 | 28102081 | |
81 | Ubiquitination | NRLKVTSKEGLTPYP CEEEEECCCCCCCCC | 46.57 | - | |
100 | Ubiquitination | AGSIPVTKPELPKKP CCCCCCCCCCCCCCC | 36.41 | - | |
106 | Ubiquitination | TKPELPKKPNPGLIR CCCCCCCCCCCCCCC | 48.35 | - | |
131 | Phosphorylation | PLAESSDSGKKVPTP CCCCCCCCCCCCCCC | 55.23 | 28555341 | |
137 | Phosphorylation | DSGKKVPTPAPRPLL CCCCCCCCCCCCCEE | 34.76 | 23312004 | |
146 | Methylation | APRPLLLKKSVSSEN CCCCEEEECCCCCCC | 42.86 | 115981297 | |
147 | Methylation | PRPLLLKKSVSSENP CCCEEEECCCCCCCC | 56.94 | 115981305 | |
148 | Phosphorylation | RPLLLKKSVSSENPT CCEEEECCCCCCCCC | 26.16 | 26657352 | |
150 | Phosphorylation | LLLKKSVSSENPTYP EEEECCCCCCCCCCC | 38.74 | 25159151 | |
151 | Phosphorylation | LLKKSVSSENPTYPS EEECCCCCCCCCCCC | 38.96 | 26657352 | |
155 | Phosphorylation | SVSSENPTYPSAPLK CCCCCCCCCCCCCCC | 60.70 | 28450419 | |
156 | Phosphorylation | VSSENPTYPSAPLKP CCCCCCCCCCCCCCC | 9.10 | 26657352 | |
158 | Phosphorylation | SENPTYPSAPLKPVT CCCCCCCCCCCCCCC | 31.91 | 29978859 | |
162 | Ubiquitination | TYPSAPLKPVTVPPR CCCCCCCCCCCCCHH | 36.06 | - | |
165 | Phosphorylation | SAPLKPVTVPPRLAG CCCCCCCCCCHHHCC | 35.50 | 23312004 | |
177 | Ubiquitination | LAGASQAKAYKSLGE HCCHHHHHHHHHHCC | 44.61 | - | |
180 | Methylation | ASQAKAYKSLGEGPP HHHHHHHHHHCCCCC | 44.03 | 115981313 | |
180 | Ubiquitination | ASQAKAYKSLGEGPP HHHHHHHHHHCCCCC | 44.03 | - | |
181 | Phosphorylation | SQAKAYKSLGEGPPA HHHHHHHHHCCCCCC | 29.00 | 27251275 | |
197 | Phosphorylation | PPVPVLQSKPLVDID CCCCCCCCCCCEEEE | 31.89 | 24719451 | |
240 | Phosphorylation | PFQLPAKTEPIKERA CCCCCCCCCCCHHCC | 49.45 | - | |
253 | Phosphorylation | RAVQPAPTRKPTVIR CCCCCCCCCCCEEEE | 54.13 | - | |
257 | Phosphorylation | PAPTRKPTVIRIPAK CCCCCCCEEEEEECC | 31.44 | - | |
275 | Phosphorylation | CLHEDPQSPPPLPAE CCCCCCCCCCCCCCC | 44.77 | 25159151 | |
358 | Phosphorylation | KLSATRRSNKKLPFN CCCCCCCCCCCCCCC | 50.11 | 24501219 | |
367 | Phosphorylation | KKLPFNRSSSDMDLQ CCCCCCCCCCHHHHH | 34.99 | 23403867 | |
368 | Phosphorylation | KLPFNRSSSDMDLQK CCCCCCCCCHHHHHH | 27.41 | 27794612 | |
369 | Phosphorylation | LPFNRSSSDMDLQKK CCCCCCCCHHHHHHH | 37.90 | 25159151 | |
378 | Phosphorylation | MDLQKKQSNLATGLS HHHHHHHHHHHHHHH | 42.57 | 27251275 | |
385 | Phosphorylation | SNLATGLSKAKSQVF HHHHHHHHHHHHHHH | 31.73 | 22617229 | |
386 | Ubiquitination | NLATGLSKAKSQVFK HHHHHHHHHHHHHHC | 65.95 | - | |
389 | Phosphorylation | TGLSKAKSQVFKNQD HHHHHHHHHHHCCCC | 36.11 | 26657352 | |
410 | Phosphorylation | PKPGHPLYSKYMLSV CCCCCCCCCHHEECC | 13.94 | 27642862 | |
411 | Phosphorylation | KPGHPLYSKYMLSVP CCCCCCCCHHEECCC | 25.62 | 27642862 | |
413 | Phosphorylation | GHPLYSKYMLSVPHG CCCCCCHHEECCCCC | 9.43 | 27642862 | |
416 | Phosphorylation | LYSKYMLSVPHGIAN CCCHHEECCCCCCCC | 19.64 | 27642862 | |
435 | Phosphorylation | SQNPGELSCKRGDVL CCCCCCCCCCCCCEE | 17.19 | 27642862 | |
449 | Phosphorylation | LVMLKQTENNYLECQ EEEEEECCCCEEEEE | 40.77 | 17389395 | |
452 | Phosphorylation | LKQTENNYLECQKGE EEECCCCEEEEECCC | 18.56 | 25159151 | |
457 | Ubiquitination | NNYLECQKGEDTGRV CCEEEEECCCCCCCE | 75.76 | - | |
481 | Phosphorylation | PLDEHLRSRPNDPSH CHHHHHHCCCCCHHH | 59.45 | 20068231 | |
548 | Phosphorylation | IGIFPANYVKVIIDI CCEEECCEEEEEEEC | 12.07 | 27642862 | |
619 (in isoform 2) | Ubiquitination | - | 2.96 | - | |
642 | Ubiquitination | GANVLSTKVPLKTKK CCCCEEECCCCCCCC | 38.18 | - | |
681 | Phosphorylation | AETSDDLSFKRGDRI ECCCCCCCCCCCCEE | 35.40 | 24719451 | |
696 | Phosphorylation | QILERLDSDWCRGRL HHHHHCCCCCCCCCC | 37.29 | 27251275 | |
731 | Ubiquitination | SMLAIVPKGRKAKAL HHEEEEECCCCCEEE | 61.53 | - | |
750 | Phosphorylation | GENEDELSFKAGDII CCCCCCCCEECCCEE | 23.74 | 24719451 | |
758 | Phosphorylation | FKAGDIITELESVDD EECCCEEEEEECCCC | 34.55 | 20873877 | |
762 | Phosphorylation | DIITELESVDDDWMS CEEEEEECCCCCHHH | 43.39 | 29507054 | |
769 | Phosphorylation | SVDDDWMSGELMGKS CCCCCHHHCHHCCCC | 25.51 | 20873877 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SH319_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SH319_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SH319_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SH3Y1_HUMAN | SH3YL1 | physical | 12615363 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-150, AND MASSSPECTROMETRY. | |
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks."; Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.; Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-452, AND MASSSPECTROMETRY. |